GRTS - Gritstone bio GAAP EPS of -$0.33 beats by $0.03 revenue of $1.57M misses by $0.64M
2023-11-08 17:14:33 ET
More on Gritstone bio
- Gritstone bio: Renewed Excitement For Its COVID-19 Vaccine
- Gritstone bio (GRTS) Investor Presentation - Slideshow
- Jones starts Gritstone at buy; cites cancer, COVID-19 vaccines
- Gritstone shares rally on BARDA contract for new COVID-19 vaccine
- Seeking Alpha’s Quant Rating on Gritstone bio
For further details see:
Gritstone bio GAAP EPS of -$0.33 beats by $0.03, revenue of $1.57M misses by $0.64M